Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+)-depleted rats.
Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+)-depleted rats.
Background and purpose: Acetazolamide and dichlorphenamide are carbonic anhydrase (CA) inhibitors effective in the clinical condition of hypokalemic periodic paralysis (hypoPP). Whether these drugs prevent vacuolar myopathy, which is a pathogenic factor in hypoPP, is unknown. The effects of these drugs on the […]